Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome

Authors


Dr Mohamed-Ali Centre For Diabetes and Cardiovascular Risk, University College London Medical School, Whittington Hospital, Archway Road, London, N19 3UA, UK. Fax: +44 (0)171 2885302; E-mail: vmohamed@med.ucl.ac.uk

Abstract

OBJECTIVE

In order to examine the role of insulin-like growth factors in the pathogenesis of accelerated macrovascular disease in noninsulin-dependent diabetes mellitus (NIDDM), we investigated the relationship between the insulin resistance syndrome and the IGF axis.

DESIGN

Cross-sectional analysis of the relationship between insulin resistance syndrome variables and concentrations of IGF-1, IGF-2, IGFBP-1 and IGFBP-3 in 80 subjects with NIDDM.

RESULTS

After correcting for age, sex and body mass index, concentrations of IGFBP-1, correlated with those of HDL-cholesterol (r = 0.40; P < 0.001), triglycerides (r = − 0.24; P = 0.04), insulin (r = − 0.39; P < 0.001), intact proinsulin (r = − 0.32; P = 0.006), des 31,32 proinsulin (r = − 0.40; P = 0.001), and with insulin sensitivity (r = 0.38; P = 0.001) and PAI-1 activity (r = − 0.24; P = 0.05); IGF-1 levels only correlated with those of HDL-cholesterol (r = − 0.33; P = 0.005), and this was not explained by IGFBP-1 or insulin sensitivity. With additional correction for insulin, concentrations of IGFBP-1 still correlated with HDL-cholesterol (r = 0.40; P < 0.001), but not those of triglycerides or PAI-1 activity. There were no significant relationships between levels of IGF-2 and any of the variables investigated, and IGFBP-3 levels only correlated with those of total cholesterol (r = 0.24, P = 0.04).

CONCLUSIONS

In NIDDM, concentrations of IGFBP-1 are related to those of insulin, insulin sensitivity, serum lipoproteins and PAI-1 activity. The relationship between concentrations of IGFBP-1 and HDL-cholesterol is not explained by insulin. Concentrations of IGF-1 are linked to HDL-cholesterol, and this is not explained by levels of IGFBP-1. IGFBP-1 concentrations were related to PAI-1 activity, and this may be explained by insulin, which regulates the production of IGFBP-1 and PAI-1.

Ancillary